An Umbrella review of meta-analyses of randomized clinical trials demonstrated that IF consistently delivers notable benefits in individuals with obesity-related metabolic disorders, thereby reducing body mass index (BMI), body fat percentage, and visceral adipose tissue accumulation while simultaneously improving glucose homeostasis and insulin sensitivity [26]. The gene discussed is INS; the disease is obesity disorder.